Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Interpace Diagnostics Group Inc (NASDAQ:IDXG)

0.269
Delayed Data
As of Aug 29
 -0.0057 / -2.07%
Today’s Change
0.19
Today|||52-Week Range
2.51
-42.15%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$5.0M

Company Description

Interpace Diagnostics Group, Inc. engages in the development and commercialization molecular diagnostic tests principally focused on early detection of high potential progressors to cancer. It offers commercialized molecular tests which include PancraGen, ThyGenX, and ThyraMIR. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.

Contact Information

Interpace Diagnostics Group, Inc.
Morris Corporate Center 1 Building A
Parsippany New Jersey 07054
P:(844) 405-9655
Investor Relations:

Employees

Shareholders

Individual stakeholders3.63%
Other institutional16.45%
Mutual fund holders14.28%

Top Executives

Jack E. StoverPresident, Chief Executive Officer & Director
Nat KrishnamurtiChief Financial Officer, Secretary & Treasurer
Rhonda De StefanoVice President & Associate General Counsel
Patrick K. KaneVice President & Controller
Steve RynkowskiVP-Learning, Development & Commercial Operations